Dermira to price IPO of 5.35 million shares between $14.00 and $16.00

Citigroup, Leerink are the bookrunners; Guggenheim, Needham to assist

By Devika Patel

Knoxville, Tenn., Sept. 19 – Dermira, Inc. will sell 5.35 million common shares in its initial public offering with a 30-day greenshoe option of 802,500 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced Aug. 27.

The shares will be sold at a price expected to fall between $14.00 and $16.00 per share.

Citigroup and Leerink Partners are the joint bookrunning managers. Guggenheim Securities and Needham & Co. are the co-managers.

UCB Pharma SA has agreed to purchase up to $7.5 million of stock in a private placement at the same price per share.

Proceeds will be used for research and development, working capital, capital expenditures and other general corporate purposes.

The specialty biopharmaceutical company is based in Redwood City, Calif. The company intends to list its common stock on the Nasdaq under the symbol “DERM.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.